Costa Rica Weighs Cannabis Tourism Boom Against Legal Risks

Costa Rica’s lush rainforests and wellness retreats are drawing growing interest from cannabis travelers, but a patchwork of decriminalization, medical regulation and strict drug laws means a misstep can still turn a beach getaway into a legal ordeal.

A Medical Cannabis Market Emerges in a Tourist Hotspot

Costa Rica has moved decisively into regulated medical cannabis and industrial hemp, positioning itself as a regional hub for plant-based therapies just as global interest in wellness travel grows. A 2022 law created a framework for cannabis for medicinal and therapeutic use and for hemp for food and industrial purposes, followed by technical regulations that detail how products can be cultivated, manufactured and sold under license.

Publicly available information from the Ministry of Health and Ministry of Agriculture shows that licenses are now being issued for the production of cannabis for medical and therapeutic purposes, and that pharmacies can dispense approved products registered with health authorities. In early 2025, new technical rules were introduced to facilitate the commercialization of cannabis-based medicines, opening the door to more brands and dosage forms on the Costa Rican market.

For the country’s powerful tourism economy, this evolving medical framework hints at a new niche. Wellness resorts, medical tourism clinics and high-end pharmacies could, in theory, incorporate legal cannabinoid products into services aimed at visitors seeking pain relief, anxiety management or recovery therapies. Industry reports suggest that Latin America and the Caribbean are seen as promising regions for cannabis-related investment, and Costa Rica’s political stability and tourism reputation give it an immediate advantage.

At the same time, Costa Rica’s medical model is highly regulated and tied to formal health and pharmaceutical channels. Tourists cannot simply arrive and purchase high tetrahydrocannabinol (THC) products at leisure; access is dependent on prescriptions, product registration and licensed distribution, which limits how far this regulated market can currently stretch into typical leisure-focused cannabis tourism.

No Green Light for Recreational Use Despite Decriminalization

Despite the shift on medical cannabis, Costa Rica has not legalized recreational use. The consumption of marijuana is widely described in legal commentary and local press as decriminalized for personal use, following court interpretations that distinguish self-consumption from trafficking. However, cannabis remains an illicit substance under national health and narcotics laws, and there is no statute that authorizes open recreational sales, cafés or dispensaries.

Recent legal documents illustrate the limits of reform. A proposed law to regulate cannabis for recreational use was examined in 2025 as part of a citizen-initiated referendum process, but the Constitutional Chamber concluded that this plan clashed with the country’s international treaty obligations on narcotics control. The opinion described structural conflicts between full recreational legalization and long-standing United Nations conventions that Costa Rica has ratified.

The practical result is a gray zone that can be difficult for visitors to understand. While small-scale possession for clear personal use may not routinely lead to criminal prosecution, there is no guaranteed “safe” quantity defined in law, and enforcement practices can vary. Local legal analysis emphasizes that transporting or holding amounts that authorities consider inconsistent with personal use can trigger serious drug trafficking charges, with penalties that include substantial prison terms.

This ambiguity clashes with the expectations of international travelers from jurisdictions where regulated recreational markets exist. Visitors accustomed to retail stores and consumption lounges may assume that Costa Rica’s relaxed reputation and decriminalization talk mean similar freedoms, when in fact national law maintains strict prohibitions on commercial and public cannabis activity.

Tourism Promotion Meets Strict Official Warnings

Tourism marketing for Costa Rica focuses on beaches, biodiversity and wellness, and seldom mentions cannabis. Yet online travel forums and lifestyle outlets increasingly portray the country as a relaxed destination where using marijuana discreetly is tolerated, especially in coastal areas popular with surfers and backpackers. This informal messaging contributes to a perception that the country already functions as a soft cannabis tourism destination.

Government-facing information aimed at foreign travelers presents a far more rigid picture. The latest travel advisory from the United States, one of Costa Rica’s largest source markets, states plainly that marijuana and marijuana-related products are illegal in Costa Rica, regardless of whether they are permitted under the visitor’s home-state law. The advisory also highlights that products purchased legally elsewhere can be confiscated on arrival and that violations of local drug statutes can carry heavy penalties.

Similar guidance from other countries and international organizations reiterates that foreign nationals remain fully subject to Costa Rican law. Even medical cannabis products obtained under prescription abroad are not automatically recognized, and travelers are urged to confirm that any medications they carry are authorized locally. This creates a stark divide between informal, word-of-mouth assurances of tolerance and the black-letter rules referenced in official notices.

For tourism businesses, this tension is difficult to navigate. Promoting any kind of cannabis-related experience risks suggesting that illegal behavior is acceptable, while ignoring the issue leaves travelers to piece together their understanding from mixed online commentary. The result is an information gap that can expose both visitors and operators to unwelcome surprises.

Regional Cannabis Tourism Competition Raises the Stakes

Across Latin America and the Caribbean, several destinations have moved further toward open cannabis tourism than Costa Rica. Jamaica, for example, has allowed a regulated system of medical marijuana and has marketed “ganja-friendly” accommodations within the parameters of its domestic rules. Elsewhere, Uruguay and certain Mexican states have implemented broader recreational frameworks, though they vary in how explicitly they court tourists.

Industry reports on the region’s cannabis economy describe a patchwork of approaches, but a common thread is that destinations with clear legal structures are better positioned to capture high-value cannabis travelers. These visitors tend to be willing to spend on boutique hotels, guided experiences and wellness treatments, provided they can consume within a predictable regulatory environment.

Costa Rica, with its strong brand for eco-tourism and wellness, would appear well placed to compete. However, the country’s current legal configuration, where medical use is tightly controlled and recreational activity remains unlawful, leaves little room for the type of above-board cannabis experiences that have become familiar in parts of North America and Europe. Instead, travelers are left to rely on informal markets and private arrangements that offer none of the consumer protections associated with licensed businesses.

If neighboring countries or Caribbean islands further expand regulated cannabis offerings while Costa Rica maintains a cautious stance, analysts suggest the country could miss out on a lucrative niche. At the same time, regional law enforcement data reviewed in international drug control reports show that trafficking routes through Central America remain active, incentivizing Costa Rican policymakers to balance economic opportunity with concerns about organized crime.

Legal Pitfalls for Visitors and the Road Ahead

The legal risks for tourists in Costa Rica stem from the gap between decriminalized personal use in judicial practice and the uncompromising language of national drug laws. Even small errors can have significant consequences. Carrying cannabis concentrates, edibles or vape cartridges that appear commercially packaged may encourage authorities to treat the products as imported contraband, regardless of the quantity involved. Possessing cannabis in shared accommodations or vehicles can lead to disputes over who is responsible, especially when law enforcement suspects distribution.

Visitors also face potential complications at borders. Travelers who leave Costa Rica and transit through or return to countries where cannabis remains strictly illegal at the federal level may encounter screening questions about drug use abroad. In some jurisdictions, admitting to illegal consumption overseas can affect immigration status, professional licensing or future travel applications, even if no arrest occurred.

Legal specialists in drug policy note that Costa Rica’s binding commitments under international conventions make rapid, sweeping recreational legalization unlikely without coordinated treaty reforms. Instead, the near-term trajectory is expected to involve incremental adjustments within the medical and therapeutic framework, along with continued emphasis on public health messaging and controlled supply chains. Any future move to clarify personal-use thresholds or create tightly regulated consumption spaces for adults would require careful alignment with both domestic law and treaty obligations.

For now, travelers intrigued by Costa Rica’s emerging cannabis landscape are advised by official and independent sources alike to treat the country as a destination where cannabis remains illegal in formal terms. Those seeking wellness-oriented experiences can legally access certain medically approved products under local rules, but broader recreational cannabis tourism remains more aspiration than reality. The contrast between global perceptions and legal detail means the dream of a carefree cannabis holiday in Costa Rica still carries substantial risk.